Evidence map›Paper›PMID 40867505›Full record

ReviewBiomolecules2025

Inorganic Polyphosphate: An Emerging Regulator of Neuronal Bioenergetics and Its Implications in Neuroprotection.

Marcela Montilla, Norma Pavas-Escobar, Iveth Melissa Guatibonza-Arévalo, Alejandro Múnera, Renshen Eduardo Rivera-Melo, Felix A Ruiz

Abstract readReview
In one paragraph

Review in Biomolecules, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Inorganic Polyphosphate and Human Diseases.Progress in molecular and subcellular biology · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Marcela MontillaMedical School, Universidad Cooperativa de Colombia, Villavicencio 500003, Colombia.ORCID 0000-0003-0917-4288
Norma Pavas-EscobarMedical School, Universidad Cooperativa de Colombia, Villavicencio 500003, Colombia.
Iveth Melissa Guatibonza-ArévaloBehavioral Neurophysiology Laboratory, Physiological Sciences Department, School of Medicine, Universidad Nacional de Colombia, Bogotá 110110, Colombia.ORCID 0009-0000-9933-9933
Alejandro MúneraBehavioral Neurophysiology Laboratory, Physiological Sciences Department, School of Medicine, Universidad Nacional de Colombia, Bogotá 110110, Colombia.
Renshen Eduardo Rivera-MeloMedical School, Universidad Cooperativa de Colombia, Villavicencio 500003, Colombia.
Felix A RuizInstituto de Investigación e Innovación Biomédica de Cádiz (INiBICA) and "Department of Biomedicine, Biotechnology, and Public Health, Medical School", Universidad de Cádiz, 11003 Cadiz, Spain.ORCID 0000-0003-0748-5015

Funding

Consejería de Universidad, Investigación e Innovación CTS554
6 · The paper itself

Abstract

Inorganic polyphosphate (polyP) is an evolutionarily conserved polymer that has recently gained relevance in neuronal physiology and pathophysiology. Although its roles, such as mitochondrial bioenergetics, calcium homeostasis, and the oxidative stress response, for example, are increasingly recognized, its specific implications in neurological disorders remain underexplored. This review focuses on synthesizing the current knowledge of polyP in the context of central nervous system (CNS) diseases, highlighting how its involvement in key mitochondrial processes may influence neuronal survival and function. In particular, we examine recent evidence linking polyP to mechanisms relevant to neurodegeneration, such as the modulation of the mitochondrial permeability transition pore (mPTP), regulation of amyloid fibril formation, and oxidative stress responses. In addition, we analyze the emerging roles of polyP in inflammation and related cell signaling in CNS disorders. By organizing the existing data around the potential pathological and protective roles of polyP in the CNS, this review identifies it as a candidate of interest in the context of neurodegenerative disease mechanisms. We aim to clarify its relevance and stimulate future research on its molecular mechanisms and translational potential.

Indexed as

Energy MetabolismNeuronsNeuroprotectionPolyphosphatesAnimalsHumansMitochondriaNeurodegenerative DiseasesOxidative StressPolyphosphatesinorganic polyphosphate (polyP)mitochondrial bioenergeticsneurodegenerative diseasesneuroprotectiontherapeutic target

Identifiers

PMID40867505
PMCPMC12384015

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.